Psoriasis is a chronic, inflammatory, painful skin disease; currently there is no cure primary goal of treatment is to reduce inflammation and abnormal skin plaque formation. Psoriasis treatment market is rapidly growing due to factors such as growing prevalence, significant unmet needs, promising pipeline molecules would fuel the growth of psoriasis treatment market worldwide.  

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global psoriasis treatment market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global psoriasis treatment market. This report concludes with company profiles section that highlights major information about the key players engaged in global psoriasis treatment market. In-depth competitive environment analysis and historical years (2021) market size data are also provided in the report.      

Drug class analysis

Psoriasis is a chronic, autoimmune inflammatory skin disorder characterized by red patches of abnormal skin. Factors such as increase in prevalence of psoriasis and skin disorders and increase in treatment awareness are driving the growth of psoriasis treatment market globally. The main goal of psoriasis treatment is to reduce inflammation and to stop plaque formation. For the treatment of psoriasis medication generally given by topical, systemic or oral route; along with medication phototherapy alone or in combination with medication is widely accepted in market. Biologics such as Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade), Secukinumab (Cosentyx), Ustekinumab (Stelara), Taltz (ixekizumab) are widely used in market and newly approved biologic Siliq (brodalumab), Tremfya (Guselkumab) expected to drive significant market growth during forecast period. There are different types of medication are used in market, among these interleukin blockers held largest market share in the base year 2016, because interleukin blockers drugs such as ustekinumab, secukinumab, ixekizumab have long-term safety with lower risk of infection and malignancy. Inflammation is associated with psoriasis and thus tumor necrosis factor such as certolizumab pegol, etanercept, adalimumab, infliximab, golimumab, Vitamin D analogue (calcipotriol) and topical corticosteroids are commonly used in market. Other medication such as retinoids, calcineurin inhibitors and cyclosporine are used to reduce a plaque formation.  

By type analysis

Psoriasis is a chronic, autoimmune inflammatory skin disorder characterized by red patches of abnormal skin. Factors such as increase in incidence of psoriasis and skin disorders, increase in treatment awareness and wide availability of treatment medications are driving the growth of psoriasis treatment market globally. The main goal of psoriasis treatment is to reduce inflammation and to stop plaque formation. Psoriasis treatment market is segmented on the basis of type such as plaque, guttate, flexural or inverse, psoriatic arthritis and other type of psoriasis. It is observed that plaque psoriasis is major revenue generating segment because plaque psoriasis is most common form of psoriasis and affects more 85%–90% of people with psoriasis, approximately 2%-3% of population of the United States is affected with plaque psoriasis. There are different types of medication such as vitamin D analogue, topical retinoids, tazarotene are widely used in market.

Psoriasis is a chronic, non-communicable, painful skin disease for which there is no cure with great negative impact on patients quality of life, it can occur at any age, but more common older people. According to the International Federation of Psoriasis Associations (IFPA), about 3 percent of the world’s population has some form of psoriasis. In the base year 2021, North America dominated the psoriasis treatment market, United States is largest revenue contributor due to the upsurge in funding by government agencies and private organizations in healthcare system, higher cost of medication, higher number of psoriasis patient are factors fueling growth of psoriasis treatment market. According to the Cleveland Clinic, there are about 150,000 new cases of psoriasis every year in United States, approximately 2 percent of U.S. population is affected with psoriasis. Europe is the second largest revenue-generating regional market for psoriasis treatment due to higher number of psoriasis patient have been reported in some European region such as Faroe Islands where about 2.8% of the population is affected with psoriasis. It is observed that, currently Asia Pacific is hold smallest market share due to the factors such as lowest Incidence rate in some countries such as japan, Australia, China, India; also comparatively lower cost of medication may hinder the growth of psoriasis treatment market in Asia Pacific.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Psoriasis Treatment market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Psoriasis Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Psoriasis Treatment market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Psoriasis Treatment market?
• Which is the largest regional market for Psoriasis Treatment market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Psoriasis Treatment market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Psoriasis Treatment market worldwide?